Cereno Scientific AB (publ) (FRA:4A1)

Cereno Scientific AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-113.29	-99.53	-48.11	-27.65	-16.25	-16.02
Depreciation & Amortization	0.79	0.29	0.01	0.01	0.01	0.01
Other Operating Activities	3.96	1.43	2.48	0.36	0.91	1.1
Change in Accounts Receivable	1.11	-3.86	0.05	0.02	-0.08	-0.19
Change in Other Net Operating Assets	-8.55	-1.75	8.64	8.65	2.28	-1.04
Operating Cash Flow	-115.99	-103.42	-36.92	-18.62	-13.14	-16.14
Capital Expenditures	-2.67	-3.87	-	-	-	-0.01
Sale (Purchase) of Intangibles	-46.13	-80.9	-49.28	-57.54	-44.81	-8.22
Other Investing Activities	-0	-	-	-	-	-0.01
Investing Cash Flow	-48.8	-84.77	-49.28	-57.54	-44.81	-8.24
Long-Term Debt Issued	-	155	45	-	-	10
Total Debt Issued	185	155	45	-	-	10
Long-Term Debt Repaid	-	-	-	-5	-5	-
Net Debt Issued (Repaid)	165	155	45	-5	-5	10
Issuance of Common Stock	-	76.68	77.01	61.28	95.31	59.22
Other Financing Activities	0.13	-3.08	-15.69	-2.72	-8.74	-4.93
Financing Cash Flow	165.13	228.61	106.31	53.56	81.57	64.29
Miscellaneous Cash Flow Adjustments	-0	-0	-0	-	-	-
Net Cash Flow	0.34	40.41	20.12	-22.59	23.63	39.9
Free Cash Flow	-118.66	-107.29	-36.92	-18.62	-13.14	-16.15
Free Cash Flow Margin	-254.33%	-132.62%	-74.91%	-32.35%	-29.32%	-196.40%
Free Cash Flow Per Share	-0.41	-0.38	-0.16	-0.14	-0.13	-0.22
Cash Interest Paid	-	-	-	0.63	0.33	-
Levered Free Cash Flow	-124.11	-142.57	-70.75	-66.14	-52.39	-
Unlevered Free Cash Flow	-98.5	-126.27	-67.44	-65.86	-51.61	-
Change in Working Capital	-7.45	-5.61	8.7	8.67	2.2	-1.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.